The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
North America is the main market for donepezil, accounting for about 35% of the total market, followed by Europe with about 30%.
Donepezil's major manufacturers include Eisai, Pfizer, Teva, Novartis, etc. The top three companies account for about 60% of the market.
The global Donepezil market was valued at US$ 896.9 million in 2023 and is anticipated to reach US$ 859.5 million by 2030, witnessing a CAGR of -0.6% during the forecast period 2024-2030.
The classification of Donepezil includes 5mg, 10mg and 23mg, and the proportion of 10mg in 2017 is about 48%.
This report aims to provide a comprehensive presentation of the global market for Donepezil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Donepezil.
Report Scope
The Donepezil market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Donepezil market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Donepezil manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eisai
Pfizer
Teva
Sandoz
Apotex
Dr Reddy's Laboratories
Sun Pharmaceutical
Hansoh Pharma
Cipla
ARK PHA.LTD
Jishengtang Pharma
Luoxin
Segment by Type
5mg
10mg
23mg
Segment by Application
Hospitals
Clinics
Drugstore
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Donepezil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Donepezil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
North America is the main market for donepezil, accounting for about 35% of the total market, followed by Europe with about 30%.
Donepezil's major manufacturers include Eisai, Pfizer, Teva, Novartis, etc. The top three companies account for about 60% of the market.
The global Donepezil market was valued at US$ 896.9 million in 2023 and is anticipated to reach US$ 859.5 million by 2030, witnessing a CAGR of -0.6% during the forecast period 2024-2030.
The classification of Donepezil includes 5mg, 10mg and 23mg, and the proportion of 10mg in 2017 is about 48%.
This report aims to provide a comprehensive presentation of the global market for Donepezil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Donepezil.
Report Scope
The Donepezil market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Donepezil market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Donepezil manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eisai
Pfizer
Teva
Sandoz
Apotex
Dr Reddy's Laboratories
Sun Pharmaceutical
Hansoh Pharma
Cipla
ARK PHA.LTD
Jishengtang Pharma
Luoxin
Segment by Type
5mg
10mg
23mg
Segment by Application
Hospitals
Clinics
Drugstore
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Donepezil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Donepezil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Donepezil Market Overview
1.1 Product Overview and Scope of Donepezil
1.2 Donepezil Segment by Type
1.2.1 Global Donepezil Market Value Comparison by Type (2024-2030)
1.2.2 5mg
1.2.3 10mg
1.2.4 23mg
1.3 Donepezil Segment by Application
1.3.1 Global Donepezil Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstore
1.4 Global Donepezil Market Size Estimates and Forecasts
1.4.1 Global Donepezil Revenue 2019-2030
1.4.2 Global Donepezil Sales 2019-2030
1.4.3 Global Donepezil Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Donepezil Market Competition by Manufacturers
2.1 Global Donepezil Sales Market Share by Manufacturers (2019-2024)
2.2 Global Donepezil Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Donepezil Average Price by Manufacturers (2019-2024)
2.4 Global Donepezil Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Donepezil, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Donepezil, Product Type & Application
2.7 Donepezil Market Competitive Situation and Trends
2.7.1 Donepezil Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Donepezil Players Market Share by Revenue
2.7.3 Global Donepezil Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Donepezil Retrospective Market Scenario by Region
3.1 Global Donepezil Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Donepezil Global Donepezil Sales by Region: 2019-2030
3.2.1 Global Donepezil Sales by Region: 2019-2024
3.2.2 Global Donepezil Sales by Region: 2025-2030
3.3 Global Donepezil Global Donepezil Revenue by Region: 2019-2030
3.3.1 Global Donepezil Revenue by Region: 2019-2024
3.3.2 Global Donepezil Revenue by Region: 2025-2030
3.4 North America Donepezil Market Facts & Figures by Country
3.4.1 North America Donepezil Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Donepezil Sales by Country (2019-2030)
3.4.3 North America Donepezil Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Donepezil Market Facts & Figures by Country
3.5.1 Europe Donepezil Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Donepezil Sales by Country (2019-2030)
3.5.3 Europe Donepezil Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Donepezil Market Facts & Figures by Country
3.6.1 Asia Pacific Donepezil Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Donepezil Sales by Country (2019-2030)
3.6.3 Asia Pacific Donepezil Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Donepezil Market Facts & Figures by Country
3.7.1 Latin America Donepezil Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Donepezil Sales by Country (2019-2030)
3.7.3 Latin America Donepezil Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Donepezil Market Facts & Figures by Country
3.8.1 Middle East and Africa Donepezil Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Donepezil Sales by Country (2019-2030)
3.8.3 Middle East and Africa Donepezil Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Donepezil Sales by Type (2019-2030)
4.1.1 Global Donepezil Sales by Type (2019-2024)
4.1.2 Global Donepezil Sales by Type (2025-2030)
4.1.3 Global Donepezil Sales Market Share by Type (2019-2030)
4.2 Global Donepezil Revenue by Type (2019-2030)
4.2.1 Global Donepezil Revenue by Type (2019-2024)
4.2.2 Global Donepezil Revenue by Type (2025-2030)
4.2.3 Global Donepezil Revenue Market Share by Type (2019-2030)
4.3 Global Donepezil Price by Type (2019-2030)
5 Segment by Application
5.1 Global Donepezil Sales by Application (2019-2030)
5.1.1 Global Donepezil Sales by Application (2019-2024)
5.1.2 Global Donepezil Sales by Application (2025-2030)
5.1.3 Global Donepezil Sales Market Share by Application (2019-2030)
5.2 Global Donepezil Revenue by Application (2019-2030)
5.2.1 Global Donepezil Revenue by Application (2019-2024)
5.2.2 Global Donepezil Revenue by Application (2025-2030)
5.2.3 Global Donepezil Revenue Market Share by Application (2019-2030)
5.3 Global Donepezil Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eisai
6.1.1 Eisai Corporation Information
6.1.2 Eisai Description and Business Overview
6.1.3 Eisai Donepezil Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eisai Donepezil Product Portfolio
6.1.5 Eisai Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Donepezil Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Donepezil Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Donepezil Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Donepezil Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Corporation Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Donepezil Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sandoz Donepezil Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 Apotex
6.5.1 Apotex Corporation Information
6.5.2 Apotex Description and Business Overview
6.5.3 Apotex Donepezil Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Apotex Donepezil Product Portfolio
6.5.5 Apotex Recent Developments/Updates
6.6 Dr Reddy's Laboratories
6.6.1 Dr Reddy's Laboratories Corporation Information
6.6.2 Dr Reddy's Laboratories Description and Business Overview
6.6.3 Dr Reddy's Laboratories Donepezil Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dr Reddy's Laboratories Donepezil Product Portfolio
6.6.5 Dr Reddy's Laboratories Recent Developments/Updates
6.7 Sun Pharmaceutical
6.6.1 Sun Pharmaceutical Corporation Information
6.6.2 Sun Pharmaceutical Description and Business Overview
6.6.3 Sun Pharmaceutical Donepezil Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharmaceutical Donepezil Product Portfolio
6.7.5 Sun Pharmaceutical Recent Developments/Updates
6.8 Hansoh Pharma
6.8.1 Hansoh Pharma Corporation Information
6.8.2 Hansoh Pharma Description and Business Overview
6.8.3 Hansoh Pharma Donepezil Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hansoh Pharma Donepezil Product Portfolio
6.8.5 Hansoh Pharma Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Corporation Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Donepezil Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cipla Donepezil Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 ARK PHA.LTD
6.10.1 ARK PHA.LTD Corporation Information
6.10.2 ARK PHA.LTD Description and Business Overview
6.10.3 ARK PHA.LTD Donepezil Sales, Revenue and Gross Margin (2019-2024)
6.10.4 ARK PHA.LTD Donepezil Product Portfolio
6.10.5 ARK PHA.LTD Recent Developments/Updates
6.11 Jishengtang Pharma
6.11.1 Jishengtang Pharma Corporation Information
6.11.2 Jishengtang Pharma Donepezil Description and Business Overview
6.11.3 Jishengtang Pharma Donepezil Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Jishengtang Pharma Donepezil Product Portfolio
6.11.5 Jishengtang Pharma Recent Developments/Updates
6.12 Luoxin
6.12.1 Luoxin Corporation Information
6.12.2 Luoxin Donepezil Description and Business Overview
6.12.3 Luoxin Donepezil Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Luoxin Donepezil Product Portfolio
6.12.5 Luoxin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Donepezil Industry Chain Analysis
7.2 Donepezil Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Donepezil Production Mode & Process
7.4 Donepezil Sales and Marketing
7.4.1 Donepezil Sales Channels
7.4.2 Donepezil Distributors
7.5 Donepezil Customers
8 Donepezil Market Dynamics
8.1 Donepezil Industry Trends
8.2 Donepezil Market Drivers
8.3 Donepezil Market Challenges
8.4 Donepezil Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
